Vitamin D Status and Virologic Response to HCV Therapy in the HALT-C and VIRAHEP-C Trials

Erikka Loftfield; Thomas R. O’Brien; Ruth M. Pfeiffer; Charles D. Howell; Ron Horst; Ludmila Prokunina-Olsson; Stephanie J. Weinstein; Demetrius Albanes; Timothy R. Morgan; Neal D. Freedman

doi:10.1371/journal.pone.0166036

Loading metrics

Open Access

Peer-reviewed

Research Article

Vitamin D Status and Virologic Response to HCV Therapy in the HALT-C and VIRAHEP-C Trials

Erikka Loftfield ,

* E-mail: erikka.loftfield@nih.gov

Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States of America
⨯
Thomas R. O’Brien,

Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States of America
⨯
Ruth M. Pfeiffer,

Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States of America
⨯
Charles D. Howell,

Affiliation Department of Medicine, Howard University College of Medicine, Washington, DC, United States of America
⨯
Ron Horst,

Affiliation Heartland Assays, Ames, IA, United States of America
⨯
Ludmila Prokunina-Olsson,

Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States of America
⨯
Stephanie J. Weinstein,

Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States of America
⨯
Demetrius Albanes,

Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States of America
⨯
Timothy R. Morgan,

Affiliation VA Long Beach Healthcare System, Long Beach, CA, United States of America
⨯
Neal D. Freedman

Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States of America
⨯

Vitamin D Status and Virologic Response to HCV Therapy in the HALT-C and VIRAHEP-C Trials

Erikka Loftfield,
Thomas R. O’Brien,
Ruth M. Pfeiffer,
Charles D. Howell,
Ron Horst,
Ludmila Prokunina-Olsson,
Stephanie J. Weinstein,
Demetrius Albanes,
Timothy R. Morgan,
Neal D. Freedman

Published: November 10, 2016
https://doi.org/10.1371/journal.pone.0166036

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Vitamin D
Is the Subject Area "Vitamin D" applicable to this article?

Thanks for your feedback.
Hepatitis C virus
Is the Subject Area "Hepatitis C virus" applicable to this article?

Thanks for your feedback.
African American people
Is the Subject Area "African American people" applicable to this article?

Thanks for your feedback.
Metaanalysis
Is the Subject Area "Metaanalysis" applicable to this article?

Thanks for your feedback.
Antiviral therapy
Is the Subject Area "Antiviral therapy" applicable to this article?

Thanks for your feedback.
Cirrhosis
Is the Subject Area "Cirrhosis" applicable to this article?

Thanks for your feedback.
Liver diseases
Is the Subject Area "Liver diseases" applicable to this article?

Thanks for your feedback.
Fibrosis
Is the Subject Area "Fibrosis" applicable to this article?

Thanks for your feedback.